BioCryst Pharmaceuticals Inc (BCRX)

NASDAQ HEALTHCARE
$9.16 +1.89% RSI 48 Neutral Add Alert

Moving Averages

SMA 200
$7.87
Price above

Company Profile

BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small molecule drugs. The company is headquartered in Durham, North Carolina.

Sector
HEALTHCARE
Industry
DRUG MANUFACTURERS - SPECIALTY & GENERIC
Market Cap
$2.40B
P/E Ratio
7.9
EPS
$1.21
Beta
0.693
Dividend Yield
0.00%
52-Week High
$11.31
52-Week Low
$6

Similar stocks in DRUG MANUFACTURERS - SPECIALTY & GENERIC

HIMS
Hims & Hers Health Inc - Class A
RSI 54.0
CGC
Canopy Growth Corporation
RSI 48.0
BFRI
Biofrontera Inc
RSI 62.0
TLRY
Tilray Brands Inc - Class 2
RSI 41.0
LNTH
Lantheus Holdings Inc
RSI 52.0
ACB
Aurora Cannabis Inc
RSI 44.0

Data last updated: April 11, 2026 at 12:54 PM EDT

Track BCRX for free

Get e-mail RSI alerts when BioCryst Pharmaceuticals Inc enters oversold or overbought territory. Free forever.

Add Alert